The Patent Finder

Sumitomo Dainippon Pharma Co., Ltd.

Also on record
Records under this name other than the patents Sumitomo Dainippon Pharma Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Sumitomo Dainippon Pharma Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,273,148Method for Cancer Immunotherapy
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,765,114Method for cancer immunotherapy
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,575,308Method for cancer immunotherapy
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,980,316Stable Tablet Containing Droxidopa
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,939,627Peptides Comprising an Epitope of the Wilms Tumor Gene Product
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,067,4139-Substituted-8-OXO-ADENINE Compounds as Toll-Like Receptor (TLR7 ) Modulators
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,906,510Amide Derivative and Pharmaceutical Composition Containing the Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,178,102Emulsified Composition for Dilution and Cancer Vaccine Composition
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,541,544Molecular marker for cancer stem cell
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,399,760Molecular marker for cancer stem cell
Formerly held
In force
 · USPTO record
In forceUSPTO record
10 of 240 patents shown.
Pro members see all 240.
Pro members: see all 240 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited